Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to $364000.0.

  • Cytosorbents' Depreciation & Amortization (CF) fell 496.08% to $364000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 293.62%. This contributed to the annual value of $1.6 million for FY2024, which is 761.02% up from last year.
  • Cytosorbents' Depreciation & Amortization (CF) amounted to $364000.0 in Q3 2025, which was down 496.08% from $404497.0 recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Depreciation & Amortization (CF) registered a high of $407208.0 during Q3 2023, and its lowest value of $123751.0 during Q2 2021.
  • In the last 5 years, Cytosorbents' Depreciation & Amortization (CF) had a median value of $364000.0 in 2025 and averaged $304229.9.
  • Per our database at Business Quant, Cytosorbents' Depreciation & Amortization (CF) crashed by 2192.07% in 2021 and then soared by 9111.2% in 2023.
  • Over the past 5 years, Cytosorbents' Depreciation & Amortization (CF) (Quarter) stood at $214402.0 in 2021, then rose by 4.11% to $223214.0 in 2022, then surged by 75.29% to $391269.0 in 2023, then decreased by 0.55% to $389104.0 in 2024, then dropped by 6.45% to $364000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $364000.0 in Q3 2025, compared to $404497.0 in Q2 2025 and $368503.0 in Q1 2025.